Current Recommendations for the Systemic Treatment of Cutaneous Lupus Erythematosus During Pregnancy

Current Recommendations for the Systemic Treatment of Cutaneous Lupus Erythematosus During Pregnancy

Cutaneous lupus erythematosus (CLE) is a heterogeneous autoimmune disease of the skin that commonly affects women of childbearing age. Some of the medications used in the treatment of CLE are safe in pregnancy, whereas others are contraindicated based on their teratogenic effects. We describe the mo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cutis 2022-02, Vol.109 (2), p.90-E1
Hauptverfasser: Kirchner, Allison, Riegert, Maureen, Lake, Eden
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page E1
container_issue 2
container_start_page 90
container_title Cutis
container_volume 109
creator Kirchner, Allison
Riegert, Maureen
Lake, Eden
description Cutaneous lupus erythematosus (CLE) is a heterogeneous autoimmune disease of the skin that commonly affects women of childbearing age. Some of the medications used in the treatment of CLE are safe in pregnancy, whereas others are contraindicated based on their teratogenic effects. We describe the most recent recommendations for the use of commonly prescribed CLE medications for those who are pregnant or plan on becoming pregnant.
doi_str_mv 10.12788/cutis.0450
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2673595943</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2673595943</sourcerecordid><originalsourceid>FETCH-LOGICAL-c289t-74c82f8c8bd5c674d4f61bc350070813bac2ec10ffb8e6e515f84daa17430633</originalsourceid><addsrcrecordid>eNo9kEtLAzEUhYMgtlZX7iVLQabmMXnMUmp9QEHR7odMJqkjzaTmsZh_77RVN_dw4eNw-AC4wmiOiZDyTufUxTkqGToBU0IJL3hFqgk4j_ELIVwRIc7AhDLOKonYFLSLHILpE3w32jtn-lalzvcRWh9g-jTwY4jJuE7DdTAquT3qLVzkpHrjc4SrvBvvMgwj7FTycfwecuj6DXwLZtOrXg8X4NSqbTSXvzkD68flevFcrF6fXhb3q0ITWaVClFoSK7VsWqa5KNvSctxoyhASSGLaKE2MxsjaRhpuGGZWlq1SWJQUcUpn4OZYuwv-O5uYatdFbbbb49SacEFZxapyj94eUR18jMHYehc6p8JQY1QfTNYHk_Xe5Ehf_xbnxpn2n_3TSH8AZZpzsQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2673595943</pqid></control><display><type>article</type><title>Current Recommendations for the Systemic Treatment of Cutaneous Lupus Erythematosus During Pregnancy</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Kirchner, Allison ; Riegert, Maureen ; Lake, Eden</creator><creatorcontrib>Kirchner, Allison ; Riegert, Maureen ; Lake, Eden</creatorcontrib><description>Cutaneous lupus erythematosus (CLE) is a heterogeneous autoimmune disease of the skin that commonly affects women of childbearing age. Some of the medications used in the treatment of CLE are safe in pregnancy, whereas others are contraindicated based on their teratogenic effects. We describe the most recent recommendations for the use of commonly prescribed CLE medications for those who are pregnant or plan on becoming pregnant.</description><identifier>EISSN: 2326-6929</identifier><identifier>DOI: 10.12788/cutis.0450</identifier><identifier>PMID: 35659805</identifier><language>eng</language><publisher>United States</publisher><ispartof>Cutis, 2022-02, Vol.109 (2), p.90-E1</ispartof><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c289t-74c82f8c8bd5c674d4f61bc350070813bac2ec10ffb8e6e515f84daa17430633</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,27931,27932</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35659805$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kirchner, Allison</creatorcontrib><creatorcontrib>Riegert, Maureen</creatorcontrib><creatorcontrib>Lake, Eden</creatorcontrib><title>Current Recommendations for the Systemic Treatment of Cutaneous Lupus Erythematosus During Pregnancy</title><title>Cutis</title><addtitle>Cutis</addtitle><description>Cutaneous lupus erythematosus (CLE) is a heterogeneous autoimmune disease of the skin that commonly affects women of childbearing age. Some of the medications used in the treatment of CLE are safe in pregnancy, whereas others are contraindicated based on their teratogenic effects. We describe the most recent recommendations for the use of commonly prescribed CLE medications for those who are pregnant or plan on becoming pregnant.</description><issn>2326-6929</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNo9kEtLAzEUhYMgtlZX7iVLQabmMXnMUmp9QEHR7odMJqkjzaTmsZh_77RVN_dw4eNw-AC4wmiOiZDyTufUxTkqGToBU0IJL3hFqgk4j_ELIVwRIc7AhDLOKonYFLSLHILpE3w32jtn-lalzvcRWh9g-jTwY4jJuE7DdTAquT3qLVzkpHrjc4SrvBvvMgwj7FTycfwecuj6DXwLZtOrXg8X4NSqbTSXvzkD68flevFcrF6fXhb3q0ITWaVClFoSK7VsWqa5KNvSctxoyhASSGLaKE2MxsjaRhpuGGZWlq1SWJQUcUpn4OZYuwv-O5uYatdFbbbb49SacEFZxapyj94eUR18jMHYehc6p8JQY1QfTNYHk_Xe5Ehf_xbnxpn2n_3TSH8AZZpzsQ</recordid><startdate>202202</startdate><enddate>202202</enddate><creator>Kirchner, Allison</creator><creator>Riegert, Maureen</creator><creator>Lake, Eden</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202202</creationdate><title>Current Recommendations for the Systemic Treatment of Cutaneous Lupus Erythematosus During Pregnancy</title><author>Kirchner, Allison ; Riegert, Maureen ; Lake, Eden</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c289t-74c82f8c8bd5c674d4f61bc350070813bac2ec10ffb8e6e515f84daa17430633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Kirchner, Allison</creatorcontrib><creatorcontrib>Riegert, Maureen</creatorcontrib><creatorcontrib>Lake, Eden</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cutis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kirchner, Allison</au><au>Riegert, Maureen</au><au>Lake, Eden</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Current Recommendations for the Systemic Treatment of Cutaneous Lupus Erythematosus During Pregnancy</atitle><jtitle>Cutis</jtitle><addtitle>Cutis</addtitle><date>2022-02</date><risdate>2022</risdate><volume>109</volume><issue>2</issue><spage>90</spage><epage>E1</epage><pages>90-E1</pages><eissn>2326-6929</eissn><abstract>Cutaneous lupus erythematosus (CLE) is a heterogeneous autoimmune disease of the skin that commonly affects women of childbearing age. Some of the medications used in the treatment of CLE are safe in pregnancy, whereas others are contraindicated based on their teratogenic effects. We describe the most recent recommendations for the use of commonly prescribed CLE medications for those who are pregnant or plan on becoming pregnant.</abstract><cop>United States</cop><pmid>35659805</pmid><doi>10.12788/cutis.0450</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 2326-6929
ispartof Cutis, 2022-02, Vol.109 (2), p.90-E1
issn 2326-6929
language eng
recordid cdi_proquest_miscellaneous_2673595943
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
title Current Recommendations for the Systemic Treatment of Cutaneous Lupus Erythematosus During Pregnancy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T07%3A34%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Current%20Recommendations%20for%20the%20Systemic%20Treatment%20of%20Cutaneous%20Lupus%20Erythematosus%20During%20Pregnancy&rft.jtitle=Cutis&rft.au=Kirchner,%20Allison&rft.date=2022-02&rft.volume=109&rft.issue=2&rft.spage=90&rft.epage=E1&rft.pages=90-E1&rft.eissn=2326-6929&rft_id=info:doi/10.12788/cutis.0450&rft_dat=%3Cproquest_cross%3E2673595943%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2673595943&rft_id=info:pmid/35659805&rfr_iscdi=true